New psoriasis pill ponesimod heads to phase 3 trial
Disease control
Not yet recruiting
This study tests the safety and effectiveness of a drug called ponesimod for people with moderate-to-severe plaque psoriasis. About 300 adults aged 18 to 65 with significant skin involvement will take the medication and be monitored for side effects and symptom improvement. The g…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:27 UTC